Yuji Morine

16PUBLICATIONS
27CO-AUTHORS
Molecular targetsMedical roboticsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jan 05, 2026
Mechanism of Lenvatinib Resistance via Exosomal miRNA-132/Nrf2 Axis in Hepatocellular Carcinoma.

Chie Takasu, Chiharu Nakasu, Yu Saito

|Oct 15, 2025
Feasibility of Robotic Rectal Surgery Using the Hinotori Surgical Robot System.

Hideya Kashihara, Takuya Tokunaga, Toshiaki Yoshimoto

|Aug 23, 2025
Impact of Surgical Resection on Hepatocellular Carcinoma Following Systemic Drug Therapy: A Multicenter Retrospective Observational Study.

Takamichi Ishii, Junichi Shindoh, Ikuo Nakamura

|May 03, 2025
Vascular endothelial growth factor released from lenvatinib-resistant hepatocellular carcinoma promotes malignant behavior and drug resistance through tumor-associated macrophages.

Yukako Takehara, Yuhei Waki, Yuji Morine

|Nov 06, 2024
Lenvatinib-resistant hepatocellular carcinoma promotes malignant potential of tumor-associated macrophages via exosomal miR-301a-3p.

Yuhei Waki, Yuji Morine, Yu Saito

|Feb 09, 2023
Multiplication of tumor maximum diameter and number as a new surgical indicator for Barcelona Clinic Liver Cancer intermediate-stage hepatocellular carcinoma.

Yuji Morine, Yu Saito, Shinichiro Yamada

Pageof 3

Frequent Collaborators

8 joint publications

Yu Saito

6 joint publications

Shinichiro Yamada

4 joint publications

Tetsuya Ikemoto

2 joint publications

Toshiaki Yoshimoto